Mizuho Maintains Outperform on HCA Healthcare, Raises Price Target to $520

Benzinga · 1d ago
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $505 to $520.